Filter
2820
Filtered Results: 2820
Text search:
therapeutic
use
Featured
Recommendations
337
New Publications
686
Language
Document type
No document type
1504
Guidelines
476
Studies & Reports
440
Manuals
156
Strategic & Response Plan
90
Fact sheets
58
Training Material
44
Situation Updates
24
Brochures
13
Resource Platforms
8
Infographics
6
Dashboards/Maps
1
Countries / Regions
India
138
Global
98
South Africa
84
Kenya
79
Ethiopia
65
Uganda
55
Sierra Leone
51
Western and Central Europe
50
Nigeria
42
Nepal
41
Africa
41
Liberia
37
Ghana
34
Latin America and the Carribbean
33
Zambia
33
Tanzania
32
Rwanda
30
Bangladesh
29
Malawi
27
Namibia
27
Germany
24
Myanmar / Burma
24
Congo, Democratic Republic of
23
Brazil
21
Russia
21
Zimbabwe
20
Philippines
20
South Sudan
20
Lesotho
18
Mozambique
17
Syria
16
West and Central Africa
16
Eastern Europe
16
East and Southern Africa
15
Ukraine
14
Burkina Faso
14
Haiti
14
South–East Asia Region
14
Indonesia
14
Cambodia
12
Middle East and North Africa
12
Eswatini/ Swaziland
12
Guinea
11
Cameroon
9
Senegal
9
Asia
9
Eastern Europe and Central Asia
8
Pakistan
8
USA
7
Venezuela
7
Vietnam
6
Sudan
6
Yemen
6
Botswana
6
Benin
5
Central African Republic
5
Mali
5
Iraq
5
Tajikistan
4
Colombia
4
Thailand
4
Laos
4
Afghanistan
4
Peru
4
Bolivia
4
Angola
4
North Macedonia
3
China
3
Chile
3
Fiji
3
Burundi
3
Jordan
3
Western Pacific Region
3
Paraguay
3
United Kingdom
3
Spain
3
Bhutan
3
Serbia
2
Turkey
2
Iran
2
Albania
2
Singapore
2
Estonia
2
Niger
2
Uzbekistan
2
Armenia
2
Guinea-Bissau
2
Lithuania
2
Gabon
2
France
2
Mauritius
2
Southern Africa
2
Sri Lanka
2
Georgia
2
Poland
2
Libya
2
Madagascar
2
Switzerland
1
Mexico
1
Australia
1
Gambia
1
Kazakhstan
1
Canada
1
Kyrgyzstan
1
Congo-Brazzaville
1
Malaysia
1
Mongolia
1
Bulgaria
1
Hungary
1
Ireland
1
Saudi Arabia
1
North America
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Portugal
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Argentina
1
Papua New Guinea
1
Moldova
1
Egypt
1
Romania
1
Chad
1
Somalia
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
1022
Clinical Guidelines
289
Women & Child Health
142
Public Health
136
Key Resources
105
Pharmacy & Technologies
35
Capacity Building
34
Annual Report MEDBOX
2
Toolboxes
Mental Health
325
COVID-19
278
AMR
194
HIV
149
Pharmacy
143
TB
111
NTDs
88
Caregiver
84
Ebola
80
Rapid Response
73
NCDs
73
Disability
60
Conflict
58
Refugee
38
Planetary Health
35
Natural Hazards
29
Health Financing Toolbox
20
Global Health Education
17
Social Ethics
13
Cholera
11
Zika
11
Specific Hazards
10
Polio
10
South Sudan
1
8 January 2021
Sequencing enabled the world to rapidly identify SARS-CoV-2 and develop diagnostic tests and other tools for outbreak management. Continued genome sequencing supports the monitoring of the disease’s spread and evolution of the virus. Accelerated integration of genome sequencing int...
This Pharmaceutical Country Profile for Kenya (2010) has been developed by the Ministry of Medical Services with support of the World Health Organization. The Profile contains information on existing socio-economic and health-related conditions, resources, regulatory structures and processes and out...
One of the many gender inequities in the health and care workforce that COVID-19 has exposed is around the fit and design of Personal Protective Equipment (PPE). The rapid onset and scale of COVID-19 led to shortages of PPE in most countries, causing preventable infection and mortality among healthc...
Monkeypox is an emerging viral zoonosis with symptoms similar to those observed in smallpox patients, although less severe. Since the global eradication of smallpox in 1980, monkeypox has emerged as the most important orthopoxvirus in humans. The Advisory Committee on Variola Virus Research (ACVVR) ...
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2, ...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex...
The guidance notes describe key actions that policy-makers at national and subnational levels can take in relation to: diagnostic testing for COVID-19, clinical management of COVID-19, meeting targets for vaccination against COVID-19, maintaining infection control measures for COVID-19 in health-car...
2014-2020, Draft March 2014
Parasites & Vectors volume 15, Article number: 389 (2022)
Dengue is one of the common arboviral infections and is a public health problem in South East Asia. The aim of this systematic review and meta-analysis was to evaluate the prevalence and distribution of dengue in SAARC (South Asian Associ...
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IP...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
The key actions, activities, and approaches in this document are organized within each of the 5Cs (see Table 1 in the PDF) and those of the Strategic preparedness and response plan (SPRP) pillars as follows:
National action plan key activities, prioritized for the current context and the current ...
interim guidance, 25 November 2024
The Zambia Population Based HIV impact assessment of 2016, reported the prevalence of viral hepatitis in Zambia as ranging between 5.6% among adults aged 15 to 59% in the general population, and 7.1% among HIV infected individuals. It is estimated that the majority of persons with chronic hepatitis ...
